In a move that caught most observers by surprise, Digene CEO and founder Evan Jones said he plans to retire after 16 years at the helm. Digene is profitable and has been developing a test that identifies the virus that causes cervical cancer. His successor will be recruited from outside the company.
Isolagen has named Nicholas Teti CEO and chairman. Susan Ciallella, who will stay on as president, acted as interim CEO after Frank DeLape resigned.
Penwest Pharmaceuticals has named Jennifer L. Good, the company's current president and COO, to the position of CEO and a member of the board of directors.
Michael J. McKelvey has been named president and CEO at eResearch Technology.
MicroIslet announced that Dr. James R. Gavin III, M.D., Ph.D, who was appointed interim president and CEO of MicroIslet in January, has been named president and CEO.
Enzo Biochem has named Carl W. Balezentis, Ph.D. to the newly-created position of president of Enzo Life Sciences.
NeoPharm announced that Lawrence A. Kenyon has tendered his resignation as the company's executive vice president, CFO and corporate secretary.
NexMed announced that Vivian Liu, the company's executive vice president, has also been appointed to serve as its COO.
Carsten Boess has joined Insulet Corporation as CFO.
Cardiome Pharma has named Curtis Sikorsky, CA to the position of CFO.
Nabi Biopharmaceuticals has appointed Jordan I. Siegel as the company's senior vice president, finance, CFO and treasurer.
Russ Austin is being promoted to senior vice president, general counsel, and board secretary at Battelle.
Laura Brege has been appointed executive vice president and chief business officer of Onyx Pharmaceuticals.
Proprius Pharmaceuticals has named David W. Anderson, Ph.D. as its new chief scientific officer.
Sidney Mazel, Ph.D. has joined the management team of MedImmune as senior vice president, product planning and portfolio management.
Altus Pharmaceuticals has named Burkhard Blank, M.D. as senior vice president medicine, regulatory affairs and project management.
Novavax has appointed Mariann Caprino vice president of corporate communications and investor relations.
Cubist Pharmaceuticals has appointed Sylvie Gregoire, Pharm. D., to its board of directors.
VasoGenix Pharmaceuticals has named Jerome A. Halperin, recently retired from the Food & Drug Law Institute as president and CEO, to its board of directors.
John Macomber has been named to the board of directors of Stem Cell Innovations.
QLT has appointed Dr. Ian John Massey to its board of directors.
Kosan Biosciences has elected Kevan Clemens, Ph.D., to its board of directors.
BioSyntech has elected Dr. Joyce Tsang to its board of directors.
Aspreva Pharmaceuticals has named William Hunter, MD, MSc to its board.
William R. Mattson, Jr. has been elected to Oscient Pharmaceuticals' board of directors.